Find similar content

Source channel @githubtrending · Post #14926 · Jul 8

#jupyter_notebook#artificial_intelligence#book#large_language_models#llm#llms#oreilly#oreilly_books You can learn how to use Large Language Models (LLMs) effectively through the book *Hands-On Large Language Models* by Jay Alammar and Maarten Grootendorst. This book uses nearly 300 custom illustrations to explain key concepts and practical tools for working with LLMs, including tokenization, transformers, prompt engineering, fine-tuning, and advanced text generation. It also provides runnable code examples in Google Colab, making it easy to practice and apply what you learn. This resource helps you understand and build your own LLM applications confidently, saving you time and effort in mastering complex AI technology. It’s highly recommended for anyone wanting hands-on experience with LLMs. https://github.com/HandsOnLLM/Hands-On-Large-Language-Models

Hashtags

#jupyter_notebook #artificial_intelligence #book #large_language_models #llm #llms #oreilly #oreilly_books

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment